Categories AlphaGraphs, Earnings, Health Care
Key highlights from Biogen’s (BIIB) Q3 2024 earnings results
Biogen Inc. (NASDAQ: BIIB) reported its third quarter 2024 earnings results today.
Total revenue decreased 3% year-over-year to $2.46 billion. Revenues were down 3% on a constant currency basis as well.
Net income attributable to Biogen Inc. was $388.5 million, or $2.66 per share, compared to a loss of $68.1 million, or $0.47 per share, last year. Adjusted EPS decreased 6% to $4.08.
For the full year of 2024, Biogen expects total revenue to decline by a low-single-digit percentage compared to the previous year. Adjusted EPS is expected to be $16.10-16.60.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
MU Earnings: Micron Q2 profit jumps on higher revenues, tops expectations
Semiconductor company Micron Technology Inc. (NASDAQ: MU) Thursday reported a sharp increase in revenues and earnings for the second quarter of 2025. Earnings also surpassed Wall Street's forecasts. The Idaho-headquartered
Darden Restaurants sees growth in FY25 and beyond amid menu, tech Innovations
Darden Restaurants, Inc. (NYSE: DRI) has successfully navigated the challenging market environment by constantly innovating its menu offerings and fostering customer loyalty. In the third quarter, sales and profit margin
What to look for when McCormick & Company (MKC) reports Q1 2025 earnings
Shares of McCormick & Company, Incorporated (NYSE: MKC) were down 1% on Thursday. The stock has gained 5% year-to-date. The spice giant is slated to report its first quarter 2025 earnings results
